International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Authors
Keywords
-
Journal
PHARMACOTHERAPY
Volume 39, Issue 1, Pages 10-39
Publisher
Wiley
Online
2019-02-02
DOI
10.1002/phar.2209
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Personalizing Polymyxin B Dosing Using an Adaptive Feedback Control Algorithm
- (2018) Elizabeth A. Lakota et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis
- (2018) Konstantinos Z. Vardakas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
- (2018) Mical Paul et al. LANCET INFECTIOUS DISEASES
- Colistin versus polymyxin B for the treatment of patients with multidrug-resistant Gram-negative infections: a systematic review and meta-analysis
- (2017) Konstantinos Z. Vardakas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacodynamics of dose-escalated ‘front-loading’ polymyxin B regimens against polymyxin-resistant mcr-1-harbouring Escherichia coli
- (2017) Nicholas M. Smith et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacodynamics of colistin and fosfomycin: a ‘treasure trove’ combination combats KPC-producing Klebsiella pneumoniae
- (2017) Miao Zhao et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity
- (2017) Justin R. Lenhard et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- MIC-based dose adjustment: facts and fables
- (2017) Johan W Mouton et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics/pharmacodynamics of systemically administered polymyxin B against Klebsiella pneumoniae in mouse thigh and lung infection models
- (2017) Cornelia B Landersdorfer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy and toxicity of high-dose nebulized colistin for critically ill surgical patients with ventilator-associated pneumonia caused by multidrug-resistant Acinetobacter baumannii
- (2017) Ji Young Jang et al. JOURNAL OF CRITICAL CARE
- Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
- (2017) Belén Gutiérrez-Gutiérrez et al. LANCET INFECTIOUS DISEASES
- Polymyxin Combinations Combat Escherichia coli Harboring mcr-1 and bla NDM-5 : Preparation for a Postantibiotic Era
- (2017) Zackery P. Bulman et al. mBio
- Defining the incidence and risk factors of colistin-induced acute kidney injury by KDIGO criteria
- (2017) Ryan K. Shields et al. PLoS One
- Outcomes in meningitis/ventriculitis treated with intravenous or intraventricular plus intravenous colistin
- (2016) George Fotakopoulos et al. ACTA NEUROCHIRURGICA
- Optimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosa
- (2016) Neang S. Ly et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumannii
- (2016) Brian T. Tsuji et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B
- (2016) Maria Helena Rigatto et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
- (2016) Alexandre P. Zavascki et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Colistin Methanesulfonate and Colistin in Critically Ill Patients with Acute Renal Failure Requiring Intermittent Hemodialysis
- (2016) M. Jacobs et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Escherichia coli Harboringmcr-1andblaCTX-Mon a Novel IncF Plasmid: First Report ofmcr-1in the United States
- (2016) Patrick McGann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Intrathecal or intraventricular therapy for post-neurosurgical Gram-negative meningitis: matched cohort study
- (2016) B. Shofty et al. CLINICAL MICROBIOLOGY AND INFECTION
- Inhaled Antibiotics for Gram-Negative Respiratory Infections
- (2016) Eric Wenzler et al. CLINICAL MICROBIOLOGY REVIEWS
- Challenge for higher colistin dosage in critically ill patients receiving continuous venovenous haemodiafiltration
- (2016) Ilias Karaiskos et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate
- (2016) Juan P. Horcajada et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clinical features and mortality of patients on renal replacement therapy receiving polymyxin B
- (2016) Maria Helena Rigatto et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A pharmacokinetic–pharmacodynamic (PKPD) model based onin vitrotime–kill data predicts thein vivoPK/PD index of colistin
- (2016) David D. Khan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Predicting the risk of nephrotoxicity in patients receiving colistimethate sodium: a multicentre, retrospective, cohort study: Table 1.
- (2016) Kady Phe et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Intrathecal administration of colistin for meningitis due to New Delhi metallo-β-lactamase 1(NDM-1)-producing Klebsiella pneumoniae
- (2016) Joji Inamasu et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
- (2016) Yi-Yun Liu et al. LANCET INFECTIOUS DISEASES
- Colistin- and Carbapenem-Resistant Escherichia coli Harboring mcr-1 and bla NDM-5 , Causing a Complicated Urinary Tract Infection in a Patient from the United States: TABLE 1
- (2016) José R. Mediavilla et al. mBio
- Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial
- (2016) Sami Abdellatif et al. Annals of Intensive Care
- Acute kidney injury in patients using amikacin in an era of carbapenem-resistant bacteria
- (2016) Felipe Francisco Tuon et al. Infectious Diseases
- Successful Management of Nosocomial Ventriculitis and Meningitis Caused by Extensively Drug-ResistantAcinetobacter baumanniiin Austria
- (2016) M Hoenigl et al. Canadian Journal of Infectious Diseases & Medical Microbiology
- Intraventricular colistin in Gram-negative ventriculoperitoneal shunt infection in two pediatric patients
- (2015) Ana Sofia Santos et al. ACTA NEUROCHIRURGICA
- Head and Neck Hyperpigmentation Probably Associated With Polymyxin B Therapy
- (2015) Alexandre P. Zavascki et al. ANNALS OF PHARMACOTHERAPY
- Clinical Outcomes Associated with Polymyxin B Dose in Patients with Bloodstream Infections Due to Carbapenem-Resistant Gram-Negative Rods
- (2015) Brian C. Nelson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mucin Binding Reduces Colistin Antimicrobial Activity
- (2015) Johnny X. Huang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Polymyxin B in Combination with Antimicrobials LackingIn VitroActivity versus Polymyxin B in Monotherapy in Critically Ill Patients with Acinetobacter baumannii or Pseudomonas aeruginosa Infections
- (2015) Maria Helena Rigatto et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Preliminary Clinical Study of the Effect of Ascorbic Acid on Colistin-Associated Nephrotoxicity
- (2015) Rujipas Sirijatuphat et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients
- (2015) Ilias Karaiskos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Editorial Commentary:Optimal Usage of Colistin: Are We Any Closer?
- (2015) Jason M. Pogue et al. CLINICAL INFECTIOUS DISEASES
- Colistin-associated Acute Kidney Injury in Severely Ill Patients: A Step Toward a Better Renal Care? A Prospective Cohort Study
- (2015) Lidia Dalfino et al. CLINICAL INFECTIOUS DISEASES
- Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?
- (2015) Roger L. Nation et al. CLINICAL INFECTIOUS DISEASES
- Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
- (2015) Zubair A. Qureshi et al. CLINICAL INFECTIOUS DISEASES
- The Role of Aerosolized Colistin in the Treatment of Ventilator-Associated Pneumonia
- (2015) Antonis Valachis et al. CRITICAL CARE MEDICINE
- Differences in potency and categorical agreement between colistin and polymyxin B when testing 15,377 clinical strains collected worldwide
- (2015) Helio S. Sader et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Intraventricular versus intravenous colistin for the treatment of extensively drug resistantAcinetobacter baumanniimeningitis
- (2015) P. De Bonis et al. EUROPEAN JOURNAL OF NEUROLOGY
- Incidence and Risk Factors for Colistin-Associated Nephrotoxicity
- (2015) Fatih Temocin et al. JAPANESE JOURNAL OF INFECTIOUS DISEASES
- Colistin and doripenem combinations againstPseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance
- (2015) Neang S. Ly et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study
- (2015) Maria Helena Rigatto et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study
- (2015) Mario Tumbarello et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
- (2015) Roger L Nation et al. LANCET INFECTIOUS DISEASES
- Treatment of Ventilator-Associated Pneumonia Using Intravenous Colistin Alone or in Combination with Inhaled Colistin in Critically Ill Children
- (2015) Meltem Polat et al. PEDIATRIC DRUGS
- Antimicrobial Activity and Toxicity of the Major Lipopeptide Components of Polymyxin B and Colistin: Last-Line Antibiotics against Multidrug-Resistant Gram-Negative Bacteria
- (2015) Kade D. Roberts et al. ACS Infectious Diseases
- Comparison of Intrapulmonary and Systemic Pharmacokinetics of Colistin Methanesulfonate (CMS) and Colistin after Aerosol Delivery and Intravenous Administration of CMS in Critically Ill Patients
- (2014) Matthieu Boisson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Assessment and Multicenter Cohort Study of Comparative Nephrotoxicity Rates Associated with Colistimethate versus Polymyxin B Therapy
- (2014) K. Phe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Preliminary Study of Colistin versus Colistin plus Fosfomycin for Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections
- (2014) Rujipas Sirijatuphat et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New Colistin Population Pharmacokinetic Data in Critically Ill Patients Suggesting an Alternative Loading Dose Rationale
- (2014) N. Grégoire et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
- (2014) George L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin and Polymyxin B: Peas in a Pod, or Chalk and Cheese?
- (2014) R. L. Nation et al. CLINICAL INFECTIOUS DISEASES
- Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches
- (2014) Ilias Karaiskos et al. EXPERT OPINION ON PHARMACOTHERAPY
- Characteristics, risk factors and outcomes of adult cancer patients with extensively drug-resistant Pseudomonas aeruginosa infections
- (2014) G. Samonis et al. INFECTION
- Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: case reports and review
- (2014) O. Bargiacchi et al. INFECTION
- Single- and multiple-dose pharmacokinetics and total removal of colistin in a patient with acute kidney injury undergoing extended daily dialysis
- (2014) A.-K. Strunk et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Polymyxin B and haemofiltration in an adolescent with leukaemia
- (2014) J. S. Baird JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Combination therapy for carbapenem-resistant Gram-negative bacteria
- (2014) M. Paul et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Effective removal of colistin methanesulphonate and formed colistin during intermittent haemodialysis in a patient infected by polymyxin-only-susceptiblePseudomonas aeruginosa
- (2014) Sonia Luque et al. JOURNAL OF CHEMOTHERAPY
- Efficient removal of colistin A and B in critically ill patients undergoing CVVHDF and sorbent technologies
- (2014) Filippo Mariano et al. JOURNAL OF NEPHROLOGY
- Systematic Review and Meta-Analysis ofIn VitroSynergy of Polymyxins and Carbapenems
- (2013) Oren Zusman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Quantifying Subpopulation Synergy for Antibiotic Combinations via Mechanism-Based Modeling and a Sequential Dosing Design
- (2013) Cornelia B. Landersdorfer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Experience of Colistin-Glycopeptide Combination in Critically Ill Patients Infected with Gram-Negative Bacteria
- (2013) Nicola Petrosillo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study
- (2013) Luisa Sorlí et al. BMC INFECTIOUS DISEASES
- Clinical Efficacy and Safety of the Combination of Colistin plus Vancomycin for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
- (2013) José Garnacho-Montero et al. CHEMOTHERAPY
- The Urgent Need for Clear and Accurate Information on the Polymyxins
- (2013) R. L. Nation et al. CLINICAL INFECTIOUS DISEASES
- Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
- (2013) Emanuele Durante-Mangoni et al. CLINICAL INFECTIOUS DISEASES
- Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
- (2013) Ana M. Sandri et al. CLINICAL INFECTIOUS DISEASES
- Consistent Global Approach on Reporting of Colistin Doses to Promote Safe and Effective Use
- (2013) R. L. Nation et al. CLINICAL INFECTIOUS DISEASES
- Higher Incidence of Acute Kidney Injury With Intravenous Colistimethate Sodium Compared With Polymyxin B in Critically Ill Patients at a Tertiary Care Medical Center
- (2013) Darowan S. Akajagbor et al. CLINICAL INFECTIOUS DISEASES
- Aerosol therapy during mechanical ventilation: an international survey
- (2013) Stephan Ehrmann et al. INTENSIVE CARE MEDICINE
- Intravenous colistin in a patient with serious burns and borderline syndrome: The benefits of therapeutic drug monitoring
- (2013) Stefanie M. Bode-Böger et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review
- (2013) Ilias Karaiskos et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Extensively drug-resistant Pseudomonas aeruginosa ventriculitis and meningitis treated with intrathecal colistin
- (2013) Gul Karagoz et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium
- (2013) Felipe F. Tuon et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Colistin MIC Variability by Method for Contemporary Clinical Isolates of Multidrug-Resistant Gram-Negative Bacilli
- (2013) J. A. Hindler et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Intraventricular and lumbar intrathecal administration of antibiotics in postneurosurgical patients with meningitis and/or ventriculitis in a serious clinical state
- (2013) František Remeš et al. JOURNAL OF NEUROSURGERY
- Aerosolized Antibiotics for Ventilator-associated Pneumonia
- (2012) Jean-Jacques Rouby et al. ANESTHESIOLOGY
- Efficacy of High-dose Nebulized Colistin in Ventilator-associated Pneumonia Caused by Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
- (2012) Qin Lu et al. ANESTHESIOLOGY
- Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
- (2012) Zubair A. Qureshi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill
- (2012) Ami F. Mohamed et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Two-Component Regulatory Systems PhoP-PhoQ and PmrA-PmrB on Colistin Pharmacodynamics in Pseudomonas aeruginosa
- (2012) Neang S. Ly et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Colistin in Cerebrospinal Fluid after Intraventricular Administration of Colistin Methanesulfonate
- (2012) Roberto Imberti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Methanesulfonate and Colistin Pharmacokinetics in Critically Ill Patients Receiving Continuous Venovenous Hemodiafiltration
- (2012) Matti Karvanen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Combination of Colistin and Doripenem Is Synergistic against Klebsiella pneumoniae at Multiple Inocula and Suppresses Colistin Resistance in anIn VitroPharmacokinetic/Pharmacodynamic Model
- (2012) Zakuan Z. Deris et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Incidence and Predictors of Nephrotoxicity Associated with Intravenous Colistin in Overweight and Obese Patients
- (2012) Timothy P. Gauthier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VivoPharmacokinetics/Pharmacodynamics of Colistin and Imipenem in Pseudomonas aeruginosa Biofilm Infection
- (2012) Wang Hengzhuang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization of Polymyxin B-Induced Nephrotoxicity: Implications for Dosing Regimen Design
- (2012) Kamilia Abdelraouf et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
- (2012) M. Tumbarello et al. CLINICAL INFECTIOUS DISEASES
- Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia
- (2012) H. AYDEMIR et al. EPIDEMIOLOGY AND INFECTION
- Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients
- (2012) Zoe E. Athanassa et al. INTENSIVE CARE MEDICINE
- Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis
- (2012) A. M. Sandri et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Colistin pharmacokinetics in intensive care unit patients on continuous venovenous haemodiafiltration: an observational study
- (2012) N. Markou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment?
- (2012) Gamze Kalin et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
- (2011) S. M. Garonzik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Polymyxin B in a Patient With Renal Insufficiency: A Case Report
- (2011) A. L. H. Kwa et al. CLINICAL INFECTIOUS DISEASES
- Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health System
- (2011) J. M. Pogue et al. CLINICAL INFECTIOUS DISEASES
- Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment
- (2011) O. Zarkotou et al. CLINICAL MICROBIOLOGY AND INFECTION
- Pharmacokinetics of Colistin and Colistimethate Sodium After a Single 80-mg Intravenous Dose of CMS in Young Healthy Volunteers
- (2011) W Couet et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics
- (2011) J. M. Yousef et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Convulsions and apnoea in a patient infected with New Delhi metallo-β-lactamase-1 Escherichia coli treated with colistin
- (2011) Herbert D. Spapen et al. JOURNAL OF INFECTION
- Sepsis and Acute Kidney Injury
- (2011) A. Zarjou et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Potent Synergy and Sustained Bactericidal Activity of a Vancomycin-Colistin Combination versus Multidrug-Resistant Strains of Acinetobacter baumannii
- (2010) N. C. Gordon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Attenuation of Colistin Bactericidal Activity by High Inoculum of Pseudomonas aeruginosa Characterized by a New Mechanism-Based Population Pharmacodynamic Model
- (2010) J. B. Bulitta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Serum and Cerebrospinal Fluid Levels of Colistin in Pediatric Patients
- (2010) C. Antachopoulos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Outbreak of Colistin-Resistant, Carbapenem-ResistantKlebsiella pneumoniaein Metropolitan Detroit, Michigan
- (2010) Dror Marchaim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model
- (2010) P. J. Bergen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria
- (2010) P. Rattanaumpawan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibiotic
- (2010) L. S. Elias et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Removal of colistin during intermittent haemodialysis in two critically ill patients
- (2010) S. Marchand et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Risk factors for colistin-associated nephrotoxicity
- (2010) Pinyo Rattanaumpawan et al. JOURNAL OF INFECTION
- Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing
- (2010) Lauren M Lim et al. PHARMACOTHERAPY
- Penetration of Colistin into Cerebrospinal Fluid
- (2009) S. L. Markantonis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
- (2009) D. Plachouras et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock
- (2009) Anand Kumar et al. CHEST
- Polymyxin B and colistimethate are comparable as to efficacy and renal toxicity
- (2009) Maura S. Oliveira et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients
- (2009) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Management of meningitis due to antibiotic-resistant Acinetobacter species
- (2009) Baek-Nam Kim et al. LANCET INFECTIOUS DISEASES
- Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients
- (2008) Alexandre P. Zavascki et al. CLINICAL INFECTIOUS DISEASES
- Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model
- (2008) P. J. Bergen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
- Pharmacokinetics of polymyxin B1 in patients with multidrug-resistant Gram-negative bacterial infections
- (2007) Andrea L.H. Kwa et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started